Aperio Group, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 3.89 and the average weighting 0.4%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,841,000
+15.5%
18,516
+10.7%
0.01%0.0%
Q3 2020$1,594,000
-24.5%
16,722
-11.4%
0.01%
-37.5%
Q2 2020$2,111,000
+31.6%
18,869
-14.4%
0.01%
+14.3%
Q1 2020$1,604,000
-27.2%
22,053
+4.4%
0.01%
-12.5%
Q4 2019$2,203,000
+9.2%
21,125
+4.3%
0.01%0.0%
Q3 2019$2,017,000
-17.1%
20,260
-5.0%
0.01%
-20.0%
Q2 2019$2,434,000
-7.7%
21,322
+1.7%
0.01%
-9.1%
Q1 2019$2,636,000
-11.2%
20,967
-4.2%
0.01%
-26.7%
Q4 2018$2,969,000
-55.4%
21,876
-9.8%
0.02%
-48.3%
Q3 2018$6,655,000
+34.7%
24,245
+1.7%
0.03%
+20.8%
Q2 2018$4,940,000
+22.5%
23,848
-2.3%
0.02%
+20.0%
Q1 2018$4,034,000
+22.8%
24,421
+1.8%
0.02%
+17.6%
Q4 2017$3,284,000
+20.1%
23,980
+19.4%
0.02%
+13.3%
Q3 2017$2,734,000
+15.6%
20,080
+3.1%
0.02%
+7.1%
Q2 2017$2,365,000
+142.3%
19,485
+111.2%
0.01%
+100.0%
Q1 2017$976,000
+37.3%
9,225
+31.9%
0.01%
+40.0%
Q4 2016$711,000
-14.4%
6,996
-14.1%
0.01%
-16.7%
Q3 2016$831,000
+3.1%
8,141
+20.4%
0.01%0.0%
Q2 2016$806,000
+29.0%
6,759
+15.9%
0.01%
+20.0%
Q1 2016$625,000
+43.3%
5,833
+45.0%
0.01%
+25.0%
Q4 2015$436,000
+52.4%
4,023
+20.5%
0.00%
+33.3%
Q3 2015$286,000
-9.2%
3,338
+7.0%
0.00%0.0%
Q2 2015$315,000
+50.0%
3,119
+14.3%
0.00%
+50.0%
Q1 2015$210,0002,7290.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders